Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.61 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 4/20 | 0.38 |
| ▸ | MMP13 | P45452 | 4/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2296708 | 1.00 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL15518119 | 1.00 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL23528833 | 0.93 | GPR84 (0.70) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL21552704 | 0.93 | GPR84 (0.70) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL4759399 | 0.93 | GPR84 (0.70) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL28922166 | 0.88 | GPR84 (0.67) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL4749028 | 0.86 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL667381 | 0.86 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL16600523 | 0.86 | SLC22A6 (0.57) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL27623054 | 0.84 | SLC22A6 (0.55) | GPR84SLC22A6MAPTGABRR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12439944-B2 | 3-hydroxybutyrate compounds for use in reducing liver fat | TDELTAS LIMITED (GB) | 2025-10-14 | — | — | US | claimed |
| US-11566268-B2 | Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate | GOVERNMENT OF THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-01-31 | — | — | US | claimed |
| US-10821062-B2 | Compound for use in protecting skin | TDELTAS LIMITED (GB) | 2020-11-03 | — | — | US | claimed |
| US-10660958-B2 | Nutritional composition | TDELTAS LIMITED (GB) | 2020-05-26 | — | — | US | claimed |
| EP-2539312-B1 | NUTRITIONAL COMPOSITION | TDELTAS LTD (GB) | 2019-01-16 | — | — | EP | claimed |
| EP-1648952-B1 | NUTRITIONAL SUPPLEMENTS AND THERAPEUTIC COMPOSITIONS COMPRISING (R)-3-HYDROXYBUTYRATE DERIVATIVES | THE US GOV AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-03-07 | — | — | EP | claimed |
| US-20130102663-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2013-04-25 | — | — | US | claimed |
| US-20120064611-A1 | Process For The Preparation of (3R)-Hydroxybutyl (3R) -Hydroxybutyrate By Enzymatic Enantioselective Reduction Employing Lactobacillus Brevis Alcohol Dehydrogenase | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2012-03-15 | — | — | US | claimed |
| EP-2419519-A1 | PROCESS FOR THE PREPARATION OF (3R)-HYDR0XYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE | Isis Innovation Limited (GB) | 2012-02-22 | — | — | EP | claimed |
| WO-2026090617-A1 | PHARMACEUTICAL COMPOSITIONS AND POSTBIOTIC SUPPLEMENT COMPOSITIONS OF MICROBIALLY PRODUCED L-1,2-PROPANEDIOL AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108442-A1 | COMPOUND FOR USE IN PROTECTING SKIN | TDELTAS LTD (GB) | 2026-04-23 | — | — | US | disclosed |
| EP-4721735-A1 | COMPOSITION FOR ENTERAL NUTRITION OF CANCER PATIENTS | Kyon Biotech AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4714505-A2 | COMPOUND FOR USE IN PROTECTING SKIN | Tdeltas Limited (GB) | 2026-03-25 | — | — | EP | disclosed |
| EP-3860584-B1 | COMPOUNDS FOR USE IN PREVENTING OR TREATING ATHLETE OVERTRAINING | TDELTAS LTD (GB) | 2026-02-18 | — | — | EP | disclosed |
| WO-2019234402-A1 | COMPOUNDS FOR USE IN CANCER CACHEXIA | TDELTAS LIMITED (GB) | 2019-12-12 | — | — | WO | disclosed |
| EP-2539312-B1 | NUTRITIONAL COMPOSITION | TDELTAS LTD (GB) | 2019-01-16 | — | — | EP | disclosed |
| EP-1648952-B1 | NUTRITIONAL SUPPLEMENTS AND THERAPEUTIC COMPOSITIONS COMPRISING (R)-3-HYDROXYBUTYRATE DERIVATIVES | THE US GOV AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-03-07 | — | — | EP | disclosed |
| US-20160030314-A1 | COMPOUND FOR USE IN PROTECTING SKIN | GOVERNMENT OF THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2016-02-04 | — | — | US | disclosed |
| EP-2968091-A1 | COMPOUND FOR USE IN PROTECTING SKIN | Tdeltas Limited (GB) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014139599-A1 | COMPOUND FOR USE IN PROTECTING SKIN | TDELTAS LIMITED (GB) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064611-A1 | Process For The Preparation of (3R)-Hydroxybutyl (3R) -Hydroxybutyrate By Enzymatic Enantioselective Reduction Employing Lactobacillus Brevis Alcohol Dehydrogenase | ADH5, ADH1A, ADH1C | GPR84 1421/4885SLC22A6 3403/4885MAPT 3649/4885 |
| US-20260108442-A1 | COMPOUND FOR USE IN PROTECTING SKIN | CUTA, POT1, CETP | GPR84 3418/4885SLC22A6 2338/4885MAPT 552/4885 |
| US-11566268-B2 | Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate | HCAR3, HSD17B12, HSD17B10 | GPR84 355/4885SLC22A6 2454/4885MAPT 2040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.